Monitoring Calcific Aortic Valve Disease: The Role of Biomarkers

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|16|2548-2554

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.16, 2012-06, pp. : 2548-2554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Percutaneous Treatment of Aortic Valve Disease: Contemporary Overview and Future Trends

By  

Current Pharmaceutical Design, Vol. 23, Iss. 31, 2017-12 ,pp. : 4687-4695

Bentham Science Publishers

Access to resources Recommend Favorite

Cabergoline: Aortic valve insufficiency: case report

By  

Reactions Weekly, Vol. 1, Iss. 1197, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Dexfenfluramine: Aortic valve insufficiency: case report

By  

Reactions Weekly, Vol. 1, Iss. 1287, 2010-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Cabergoline: Aortic and mitral valve regurgitation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 285-300

Bentham Science Publishers

Access to resources Recommend Favorite